Early Outcomes and the Virological Effect of Delayed Treatment Switching to Second-Line Therapy in An Antiretroviral Roll-Out Programme in South Africa | Zendy

Julie H. Levison | Zendy; Catherine Orrell | Zendy; Elena Losina | Zendy; Zhigang Lu | Zendy; Kenneth A. Freedberg | Zendy; Robin Wood | Zendy

Open Access

Early Outcomes and the Virological Effect of Delayed Treatment Switching to Second-Line Therapy in An Antiretroviral Roll-Out Programme in South Africa

Author(s) -

Julie H. Levison,

Catherine Orrell,

Elena Losina,

Zhigang Lu,

Kenneth A. Freedberg,

Robin Wood

Publication year - 2011

Publication title -

antiviral therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.747

H-Index - 87

eISSN - 2040-2058

pISSN - 1359-6535

DOI - 10.3851/imp1819

Subject(s) - zidovudine , medicine , viral load , didanosine , multivariate analysis , lopinavir , ritonavir , retrospective cohort study , antiretroviral therapy , human immunodeficiency virus (hiv) , virology , immunology , viral disease

More patients in resource-limited settings are starting second-line antiretroviral treatment (ART) following first-line ART failure. We aimed to describe predictors of lack of virological suppression in HIV-infected patients on second-line ART in a roll-out programme in South Africa.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research